Association of circulating endothelin and noradrenaline with increased calcium-channel binding sites in the placental bed in pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 10, 1998, Pages 1104-1112

  Ferreira De Almeida, José A ^a   Amenta, Francesco ^c   Cardoso, Filomena ^a   Polónia, Jorge J ^b  

^a Fuculty of Medicine of Oporto   (Portugal)

^b Pharmacology and Therapeutics Institute   (Portugal)

^c UNIVERSITY OF CAMERINO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; DIHYDROPYRIDINE; ENDOTHELIN; ISRADIPINE; NORADRENALIN; SILVER; TRITIUM; 1,4 DIHYDROPYRIDINE; 1,4-DIHYDROPYRIDINE; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; ENDOTHELIN 1;

ADULT; ARTERY WALL; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; NORADRENALIN BLOOD LEVEL; PLACENTA; PLACENTA PERFUSION; PREECLAMPSIA; PRIMIGRAVIDA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCATCHARD PLOT; VASOCONSTRICTION; CLINICAL TRIAL; COMPARATIVE STUDY; METABOLISM; PREGNANCY; THIRD TRIMESTER PREGNANCY;

ADULT; AUTORADIOGRAPHY; BINDING SITES; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; DIHYDROPYRIDINES; ENDOTHELIN-1; FEMALE; HUMANS; NOREPINEPHRINE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD;

EID: 0031595756     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb09944.x     Document Type: Article

References (42)

1. Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155: 501–509.
2. Rubin PC. Hypertension in pregnancy. J Hypertens 1987; 5 (Suppl 3): S57–S60.
3. Terragno NA, Terrdgno A. Mechanism of hypertension in preg nancy. Semin Nephrol 1988; 8: 138–146.
4. Brinkman 111 CR. Maternal cardiovascular and renal disorders—biologic adaptation to pregnancy. In: Creasy RK, Resnick R, editors. Maternal-Fetal Medicine: Principles and Practice. WB, Saunders: Philadelphia, 1984: 679–691.
5. Talledo OE, Chesley LC, Zuspan FP. Renin-angiotensin system in normal and toxemic pregnancies. III. Differential sensitivity to angiotensin II and norepinephrine in toxemia of pregnancy. Am J Obstet Gynecol 1968; 100: 218–221.
6. Gant NF, Daley GL, Chand S, Whalley PJ, MacDonald PCA study of angiotensin II pressor responses throughout primigravid pregnancy. J Clin Invest 1913; 52:2682–2689.
7. Remuzzi G, Ruggenenti P. Prevention and treatment of pregnancy-associated hypertension: What have we learned in the last 10 years Am J Kidney Dis 1991; 18:285–305.
8. Walsh SW. Preeclampsia: An imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985; 152:335–340.
9. Hunyor SN. Hemodynamics in pregnancy and in pregnancy hyper tension. In: Zanchetti A, Tarazi RC, editors. Handbook of Hypertension, Pathophysiology of Hypertension: Cardiovascular Aspects. Vol 7. Amsterdam : Elsevier Science Publishers, 1986: 298–310.
10. Roberts JM, Taylor RM, Golfein A. Clinical and biochemical evidence of endothelial cell disfunction in the pregnancy syndrome preeclampsia. Am J Hypertens 1991; 4: 700–708.
11. m and a com puter-linked gamma camera. Clin Exp Hypertens 1982; B11: 101–110.
12. Weiner CP. The clinical spectrum of preeclampsia. Am J Kidney Dis 1987; 4: 312–316.
13. Sjoberg T, Andersson KE, Norgren L, Steen S. Comparative effects of some calcium-channel blockers on human peripheral arteries and veins. Acta Physiol Scand 1987; 130:419–427.
14. Luscher TF, Yang Z, Kiowski W, Linder L, Dohi Y, Diederich D. Endothelin-induced vasoconstriction and calcium antagonists. J Hum Hypertens 1992; 6 (Suppl 2): S3–S8.
15. Kiowski W, Luscher TF, Linder L, Buhler FR. Endothelin-l-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 1991, 83: 469–475.
16. Forman A, Andersson KE, Maigaard S. Effects of calcium chanell blockers on the female genital tract. Ada Pharmacol Toxicol 1986; 58 (Suppl 2): 183–192.
17. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892–898.
18. Soares-da-Silva P. Preferential decarboxylation of L-threo-3, 4-dihydroxiphenylserine in rat renal tissues. Gen Pharmacol 1993; 24:75–81.
19. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K. Plasma endothelin immunorreactivity in liver disease and the hepatorrenal syndrome. N Engl J Med 1992; 327: 17741778.
20. Amenta F, Collier WL, Ricci A. Autoradiographic localization of vascular dopamine receptors. Am J Hypertens 1990; 3: 34 S–36 S.
21. Amenta F, Coppola L, Gallo P, Ferrante F. Monopoli A, Napoleone P Autoradiographic localization of D-adrenergic receptors in human large coronary arteries. Circ Res 1991; 68: 1591–1599.
22. Amenta F, Ferrante F, Ferreira-de-Almeida JA, Ricci A, Pereira-Leite L. Pharmacological characterization and autoradiographic localization of neurotransmitter receptors in umbilical vessels. In: Cosmi EV, Renzo GC, editors. Hypertension in Pregnancy. Bologna : Monduzzi Editore, 1991: 105–108.
23. De Lean A, Hancock AA, Lefkowitz RJ. Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes. Mol Pharmacol 1982; 2: 5–9.
24. Cheng YC, Prusoff WH. Relationship between inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC-50) of an enzymatic reaction. Biochem Pharmacol 1973; 22 3099–3108.
25. 3H)-opioid receptors in rat brain. Brain Res 1979; 199: 255–270.
26. De Michele M, Amenta F, Cavallotti C. Autoradiographic localization of muscarinic receptors within the rat kidney. Eur J Pharmacol 1989; 169:297–305.
27. Borges N, Polonia J. Use of spreadsheet for statistical and graphical processing of records from the ambulatory blood pressure monitor Spacelabs 90207. Rev Port Cardiol 1993; 12: 313–319.
28. Pederson EB, Rarmussen AB, Christensen NJ. Plasma noradrena-line and adrenaline in preeclampsia, essential hypertension in pregnancy and normotensive pregnant control subjects. Acta Endocrinol 1982; 99:594–600.
29. Kamoi K, Sudo N, Ishibashi M, Yamaji T. Plasma endothelin-1 levels in patients with pregnancy-induced hypertension [letter]. N Engl J Med 1990; 323: 1486–1487.
30. Polonia J, Ferreira-de-Almeida J, Matias A et al. Renin-angiotensin aldosterone, sympathetic and endothelin systems in normal and hypertensive pregnancy: Response to postural and volume load stimuli. J Hypertens 1993; 11 (Suppl 5): 8242–8243.
31. Boarder MR, Marriot DB. Characterization of endothelin-l stimulation of catecholamine release from adrenal chromafin cells / Cardiovasc Pharmacol 1989; 13 (Suppl 5): S223–S224.
32. Rasmussen H. The calcium messenger system. N Engl J Med 1986; 314: 1094–1100.
33. Robinson BF, Dobbs RJ, Kelsey CR The effects of nifedipine on the resistance vessels, arteries and veins in man. Br J Clin Pharmacol 1980; 10:433–438.
34. Dostal DE, Murahashi T, Peach MJ Regulation of cytosolic calcium by angiotensins in vascular smooth muscle. Hypertension 1990; 15: 815–822.
35. Erne P, Bolli P, Burgisser E, Buhler FR. Correlation of platelet calcium with blood pressure: Effects of antihypertensive therapy. N Engl J Med 1984; 130:1084–1088.
36. Kilby MD, Broughton Pipkin F, Symonds EM. Calcium and platelets in normotensive and hypertensive human pregnancy. J Hypertens 1992; 10:997–1003.
37. Barr SM, Lees KR, Butters L, ODonnell A, Rubin PC. Platelet intracellular free calcium concentration in normotensive and hypertensive pregnancies in the human. Clin Sci 1989; 76: 67–71.
38. Lindow SW, Davies N, Davey DA, Smith JA. The effect of sublin-gual nifedipine on uteroplacental blood flow in hypertensive pregnancy. Br J Obstet Gynaecol 1988; 5: 1276–1281.
39. Wide-Swensson D, Ingemarsson I, Andersson KE, Anandakumar C, Arulkumaran S, Ratnam SS. lsradipine reduces blood pressure, but not placental blood flow in pregancy-induced hypertension. Clin Exp Hypertens 1991; B10: 49–60.
40. Baker PN, Kilby MD, Broughton Pipkin F. The effect of angiotensin 11 on platelet intracellular free calcium concentration in human pregancy. J Hyperfens 1992; 10: 5540.
41. Triggle DJ. Sites, mechanisms of action, and differentiation of calcium channel antagonists. Am J Hypertens 1991; 4422 S–4429 S.
42. Ebata H, Natsume T, Mitsuhashi T, Yaginuma T. Reduced calcium sensitivity of dihydropyridine binding to calcium channels in spontaneously hypertensive rats. Hypertension 1991; 17:234–241.